Mazor Surgical Technologies Ltd. (TASE:MZOR) today reported that it successfully completed a series complex clinical trials for initial implementation of the company's combined robotic spinal and brain surgical system. According to Mazor, in the tests the system proved precision and stability.
The company said, "The trials were implemented with the support and supervision of a team of senior brain surgeons at Hadassah Medical Center in Jerusalem, and in the professional opinion of the researchers, the trial's success was complete and trial's goals were fully achieved."
The company also said that following the trial they are preparing to complete development of the application and will file as soon as possible a request for approval from the relevant health authorities in the US and Europe.
Mazor's share price jumped 7.1% to NIS 10.44 in early afternoon trading on the TASE today.
Published by Globes, Israel business news - www.globes-online.com - on October 12, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010